BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35287524)

  • 1. Mortality of COVID-19 is associated with comorbidity in patients with chronic obstructive pulmonary disease.
    Andreen N; Andersson LM; Sundell N; Gustavsson L; Westin J
    Infect Dis (Lond); 2022 Jul; 54(7):508-513. PubMed ID: 35287524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
    Yin T; Li Y; Ying Y; Luo Z
    BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2.
    Gómez Antúnez M; Muiño Míguez A; Bendala Estrada AD; Maestro de la Calle G; Monge Monge D; Boixeda R; Ena J; Mella Pérez C; Anton Santos JM; Lumbreras Bermejo C;
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3433-3445. PubMed ID: 33447021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia.
    Sheikh D; Tripathi N; Chandler TR; Furmanek S; Bordon J; Ramirez JA; Cavallazzi R
    Respir Med; 2022 Jan; 191():106714. PubMed ID: 34915396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of severe coronavirus disease 2019 patients with chronic obstructive pulmonary disease.
    Liang H; Lu R; Li Y; Pan P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1695-1703. PubMed ID: 36748380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
    Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
    Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD).
    He Y; Xie M; Zhao J; Liu X
    Med Sci Monit; 2020 Sep; 26():e927212. PubMed ID: 32883943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19.
    Figueira-Gonçalves JM; García-Bello MÁ; Ramallo-Fariña Y; Méndez R; Latorre Campos A; González-Jiménez P; Peces-Barba G; Molina-Molina M; España PP; García E; Domínguez-Pazos SJ; García Clemente M; Panadero C; de la Rosa-Carrillo D; Sibila O; Martínez-Pitarch MD; Toledo-Pons N; López-Ramirez C; Almonte-Batista W; Macías-Paredes A; Badenes-Bonet D; Pérez-Rodas EN; Lázaro J; Quirós Fernández S; Cordovilla R; Cano-Pumarega I; Torres A; Menendez R;
    Int J Chron Obstruct Pulmon Dis; 2023; 18():2473-2481. PubMed ID: 37955022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality risk of COVID-19 in elderly males with comorbidities: a multi-country study.
    Li G; Liu Y; Jing X; Wang Y; Miao M; Tao L; Zhou Z; Xie Y; Huang Y; Lei J; Gong G; Jin P; Hao Y; Faria NR; Clercq E; Zhang M
    Aging (Albany NY); 2020 Dec; 13(1):27-60. PubMed ID: 33472167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of covid-19 among patients with chronic obstructive pulmonary disease and tuberculosis.
    Muneeb Hassan M; Ameeq M; Jamal F; Tahir MH; Mendy JT
    Ann Med; 2023 Dec; 55(1):285-291. PubMed ID: 36594409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of hospitalization in a sample of COVID-19 patients with and without chronic obstructive pulmonary disease.
    Myers LC; Murray R; Donato B; Liu VX; Kipnis P; Shaikh A; Franchino-Elder J
    Respir Med; 2023 Jan; 206():107064. PubMed ID: 36459955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults.
    Hyams C; Qian G; Nava G; Challen R; Begier E; Southern J; Lahuerta M; Nguyen JL; King J; Morley A; Clout M; Maskell N; Jodar L; Oliver J; Ellsbury G; McLaughlin JM; Gessner BD; Finn A; Danon L; Dodd JW;
    J R Soc Med; 2023 Nov; 116(11):371-385. PubMed ID: 37404021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Courses and Outcomes of Patients with Chronic Obstructive Pulmonary Disease During the COVID-19 Epidemic in Hubei, China.
    Hu W; Dong M; Xiong M; Zhao D; Zhao Y; Wang M; Wang T; Liu Z; Lu L; Hu K
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2237-2248. PubMed ID: 33061341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection.
    Calmes D; Graff S; Maes N; Frix AN; Thys M; Bonhomme O; Berg J; Debruche M; Gester F; Henket M; Paulus V; Duysinx B; Heinen V; Dang DN; Paulus A; Quaedvlieg V; Vaillant F; Van Cauwenberge H; Malaise M; Gilbert A; Ghuysen A; Gillet P; Moutschen M; Misset B; Sibille A; Guiot J; Corhay JL; Louis R; Schleich F
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):160-169. PubMed ID: 33038592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»).
    Tarlovskaya EI; Arutyunov AG; Konradi AO; Lopatin YM; Rebrov AP; Tereshchenko SN; Chesnikova AI; Hayrapetyan HG; Babin AP; Bakulin IG; Bakulina NV; Balykova LA; Blagonravova AS; Boldina MV; Vaisberg AR; Galyavich AS; Gomonova VV; Grigorieva NY; Gubareva IV; Demko IV; Evzerikhina AV; Zharkov AV; Kamilova UK; Kim ZF; Kuznetsova TY; Lareva NV; Makarova EV; Malchikova SV; Nedogoda SV; Petrova MM; Pochinka IG; Protasov KV; Protsenko DN; Ruzanau DY; Sayganov SA; Sarybaev AS; Selezneva NM; Sugraliev AB; Fomin IV; Khlynova OV; Chizhova OY; Shaposhnik II; Shсukarev DA; Abdrahmanova AK; Avetisian SA; Avoyan HG; Azarian KK; Aimakhanova GT; Ayipova DA; Akunov AC; Alieva MK; Aparkina AV; Aruslanova OR; Ashina EY; Badina OY; Barisheva OY; Batchayeva AS; Bitieva AM; Bikhteyev IU; Borodulina NA; Bragin MV; Budu AM; Burygina LA; Bykova GA; Vagapova KR; Varlamova DD; Vezikova NN; Verbitskaya EA; Vilkova OE; Vinnikova EA; Vustina VV; Gаlova EA; Genkel VV; Gorshenina EI; Gostishev RV; Grigorieva EV; Gubareva EY; Dabylova GM; Demchenko AI; Dolgikh OY; Duyshobayev MY; Evdokimov DS; Egorova KE; Ermilova AN; Zheldybayeva AE; Zarechnova NV; Zimina YD; Ivanova SY; Ivanchenko EY; Ilina MV; Kazakovtseva MV; Kazymova EV; Kalinina YS; Kamardina NA; Karachenova AM; Karetnikov IA; Karoli NA; Karpov OV; Karsiev MK; Кaskaeva DS; Kasymova KF; Kerimbekova ZB; Kerimova AS; Kim ES; Kiseleva NV; Klimenko DA; Klimova AV; Kovalishena OV; Kolmakova EV; Kolchinskaya TP; Kolyadich MI; Kondriakova OV; Konoval MP; Konstantinov DY; Konstantinova EA; Kordukova VA; Koroleva EV; Kraposhina AY; Kriukova TV; Kuznetsova AS; Kuzmina TY; Kuzmichev KV; Kulchoroeva CK; Kuprina TV; Kouranova IM; Kurenkova LV; Kurchugina NY; Kushubakova NA; Levankova VI; Levin MЕ; Lyubavina NA; Magdeyeva NA; Mazalov KV; Majseenko VI; Makarova AS; Maripov AM; Marusina AA; Melnikov ES; Moiseenko NB; Muradova FN; Muradyan RG; Myshak AO; Nikitina NM; Ogurlieva BB; Odegova AA; Omarova YM; Omurzakova NA; Ospanova SO; Pahomova EV; Petrov LD; Plastinina SS; Pogrebetskaya VA; Polyakov DS; Ponomarenko EV; Popova LL; Prokofeva NA; Pudova IA; Rakov NA; Rakhimov AN; Rozanova NA; Serikbolkyzy S; Simonov AA; Skachkova VV; Soloveva DV; Soloveva IA; Sokhova FM; Subbotin AK; Sukhomlinova IM; Sushilova AG; Tagayeva DR; Titojkina YV; Tikhonova EP; Tokmin DS; Tolmacheva AA; Torgunakova MS; Trenogina KV; Trostianetckaia NA; Trofimov DA; Tulichev AA; Tursunova AT; Ulanova ND; Fatenkov OV; Fedorishina OV; Fil TS; Fomina IY; Fominova IS; Frolova IA; Tsvinger SM; Tsoma VV; Cholponbaeva MB; Chudinovskikh TI; Shevchenko OA; Sheshina TV; Shishkina EA; Shishkov KY; Sherbakov SY; Yausheva EA; Musaelian SN; Belenkov YN; Arutyunov GP
    Kardiologiia; 2021 Sep; 61(9):20-32. PubMed ID: 34713782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
    Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
    Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
    Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
    Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focusing on Asthma and Chronic Obstructive Pulmonary Disease with COVID-19.
    Gemicioglu B; Uzun H; Borekci S; Karaali R; Kurugoglu S; Atukeren P; Sirolu S; Durmus S; Dirican A; Kuskucu MA; Tabak F
    J Infect Dev Ctries; 2021 Oct; 15(10):1415-1425. PubMed ID: 34780364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19.
    Song J; Zeng M; Wang H; Qin C; Hou HY; Sun ZY; Xu SP; Wang GP; Guo CL; Deng YK; Wang ZC; Ma J; Pan L; Liao B; Du ZH; Feng QM; Liu Y; Xie JG; Liu Z
    Allergy; 2021 Feb; 76(2):483-496. PubMed ID: 32716553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.